Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Ref. | Year | Country | Study design | n | Procedure | Medication | Relative risk |
Varadarajulu et al[92] | 2008 | United States | Retrospective | 20 | ECG | No medications | No incidence of PPB |
Melman et al[97] | 2009 | United States | Prospective | 45 | ECG | No medications | Incidence of PPB 4.4% |
Johnson et al[93] | 2009 | United States | Retrospective | 24 | ECG | No medications | Incidence of PPB 8.3% |
Varadarajulu et al[96] | 2013 | United States | Prospective | 20 | ECG | No medications | No incidence of PPB |
Saul et al[94] | 2016 | United States | Retrospective | 21 | ECG | No medications | Incidence of PPB 9.5% |
Saluja et al[95] | 2019 | India | Retrospective | 35 | ECG | No medications | Incidence of PPB 2.9% |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408